IRIS
CAPODANNO, DAVIDE FRANCESCO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.311
EU - Europa 5.950
AS - Asia 3.341
AF - Africa 548
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
Totale 21.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.668
IE - Irlanda 1.937
CN - Cina 1.873
UA - Ucraina 1.790
SG - Singapore 1.191
IT - Italia 725
CA - Canada 642
RU - Federazione Russa 508
CI - Costa d'Avorio 471
SE - Svezia 281
GR - Grecia 194
VN - Vietnam 167
DE - Germania 114
GB - Regno Unito 84
CH - Svizzera 60
SN - Senegal 59
FR - Francia 58
FI - Finlandia 44
AT - Austria 35
IN - India 32
NL - Olanda 32
UZ - Uzbekistan 32
BE - Belgio 26
PL - Polonia 21
NG - Nigeria 16
EU - Europa 15
CZ - Repubblica Ceca 12
HK - Hong Kong 11
JP - Giappone 11
LB - Libano 9
BG - Bulgaria 8
BY - Bielorussia 3
ES - Italia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PT - Portogallo 3
GE - Georgia 2
MK - Macedonia 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
BN - Brunei Darussalam 1
BZ - Belize 1
DK - Danimarca 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 21.168
Salva come PNG Salva come JPEG
Città #
Jacksonville 2.375
Dublin 1.935
Chandler 1.396
Boardman 935
Singapore 810
Nanjing 640
Houston 619
Lawrence 542
Andover 537
Cambridge 535
Toronto 498
Abidjan 471
Chicago 419
Ashburn 378
Des Moines 377
Catania 342
San Mateo 230
Nanchang 227
Wilmington 186
Hebei 177
Shenyang 158
Dong Ket 143
Athens 136
Ottawa 135
Jiaxing 115
Saint Petersburg 114
Tianjin 114
Changsha 90
Santa Clara 70
Dakar 59
Washington 57
Los Angeles 47
Beijing 45
Moscow 45
Bremen 43
Norwalk 39
Seattle 39
Hangzhou 37
Lappeenranta 37
Kunming 34
Jinan 30
Ningbo 29
Brussels 26
Milan 26
Den Haag 24
Hanoi 24
Liberty Lake 24
Pune 24
Zhengzhou 22
Palermo 20
Gravina di Catania 18
Ann Arbor 17
Abuja 16
Edinburgh 16
Taizhou 16
Frankfurt Am Main 14
Padova 13
Pozzo Di Gotto 13
Falls Church 12
Manduria 12
Rome 12
Aigaleo 10
Changchun 10
Munich 10
Redwood City 10
Hong Kong 9
Kiev 9
Lausanne 9
Guangzhou 8
Acireale 7
Helsinki 7
Lanzhou 7
Princeton 7
Tappahannock 7
Fairfield 6
Ludwigshafen 6
Providence 6
Shanghai 6
Springfield 6
Bussero 5
Canicattini Bagni 5
Civitavecchia 5
Maletto 5
Mascalucia 5
Prineville 5
Scicli 5
Stein 5
Stockholm 5
Brno 4
Casarano 4
Fuzhou 4
Messina 4
Woodbridge 4
Amsterdam 3
Bisceglie 3
Dearborn 3
Fort Worth 3
Groningen 3
Lisbon 3
Manfredonia 3
Totale 15.820
Salva come PNG Salva come JPEG
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 495
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 213
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 109
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 106
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 96
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 69
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 68
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 67
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 65
[Management of severe stenosis controversies and promises] 63
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 61
Pre-dilation, Sizing and Post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffolds implantation for prediction of cardiac adverse events: development and internal validation of the PSP score 61
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 60
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 60
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 60
Clinical implication of different plaque distribution patterns in distal left main coronary artery 60
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 60
Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography-Guided Percutaneous Coronary Intervention With Stent Implantation: A Systematic Review and Bayesian Network Meta-Analysis of 31 Studies and 17,882 Patients 60
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 60
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 59
Quality of life assessment after percutaneous aortic valve implantation 59
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 59
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 59
Transcatheter aortic valve implantation in 2017: state of the art 59
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 59
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 58
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 58
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry 58
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 58
Pre-Defining Optimal C-Arm Position for TAVI With CT-Scan Using a Free Software 58
Clinical decision making in left main revascularization: the past, the present and the future 57
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 57
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 57
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 57
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 57
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 57
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 57
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 56
Diabetes mellitus: the scary killer haunting silently 55
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 55
CORONARY REMODELLING AFTER RECANALIZATION OF CHRONIC TOTAL OCCLUSION 55
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 55
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 55
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 55
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 54
Spontaneous coronary artery dissection 54
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 54
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 54
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 54
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 54
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 54
A Multidisciplinary Consensus Document on Follow-up Strategies for Patients Treated with Percutaneous Coronary Intervention 54
Antithrombotic Therapy in Patients with Chronic Kidney Disease 53
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 53
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 53
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 53
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 53
Update on clinical evidence (Part II): a summary of the main post market studies 53
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 53
Optimized Screening of Coronary Artery Disease With Invasive Coronary Angiography and Ad Hoc Percutaneous Coronary Intervention During Transcatheter Aortic Valve Replacement 53
Long-term clinical and echocardiographic outcomes of Mitraclip therapy in patients nonresponders to cardiac resynchronization 53
Reply: plaque rupture in stable coronary artery disease 52
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 52
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 52
Tailoring duration of DAPT with risk scores 52
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 52
Impact of race and gender on antithrombotic therapy 52
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 52
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 52
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip Implantation 52
A novel 3-d reconstruction system for the assessment of bifurcation lesions treated by the mini-crush technique 52
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 52
Prevention of Acute Kidney Injury with the RenalGuard System in patients undergoing Transcatheter Aortic Valve Implantation: The PROTECT-TAVI trial 52
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 51
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 51
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 51
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 51
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 51
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 51
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST- EU Registry - Reply 51
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 51
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 51
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 51
Guideline-driven versus non-guideline driven approach for left main coronary artery revascularization: the Appraise a customized strategy for left main revascularization (CUSTOMIZE) study 51
A post-hoc analysis of the CUSTOMIZE Registry on the differential impact of EuroSCORE and SYNTAX score in Left Main Patients with Intermediate Global Risk 51
Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts 51
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. 51
Platelet function profiles in the elderly: Results of a pharmacodynamic study in patients on clopidogrel therapy and effects of switching to prasugrel 5 mg in patients with high platelet reactivity. 51
A comparison between Endeavor and Endeavor Resolute drug-eluting coronary stents: outcomes at six month follow up 51
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 50
Unraveling the EXCEL: Promises and Challenges of the Next Trial of Left Main Percutaneous Coronary Intervention 50
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 50
The optimal pharmacological formula for percutaneous coronary intervention 50
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 50
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 50
Risk stratification after ST-elevation myocardial infarction 50
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. 50
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 50
The Sicilian Drug-eluting Stent Registry - Risk-benefits and Cost-effectiveness Analyses of Drug-eluting Stents versus Bare-metal Stents 49
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting 49
Totale 6.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.088 0 0 319 154 361 47 486 6 235 48 285 147
2020/20213.251 12 231 498 8 834 113 501 6 269 24 525 230
2021/20223.809 500 586 11 51 626 12 565 100 335 5 84 934
2022/20235.270 552 69 41 360 686 1.001 11 827 1.454 34 172 63
2023/20242.439 129 503 112 195 100 379 52 111 17 79 480 282
2024/20251.933 97 1.270 566 0 0 0 0 0 0 0 0 0
Totale 21.925